This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA

Manos Tzortzakakis
Scientist, Drug Substance Development at AstraZeneca
Speaker

Profile

Manos Tzortzakakis is a dedicated Scientist in Drug Substance group within Biopharmaceutical Development at AstraZeneca. He leads the N-1 perfusion development team and has been instrumental in the development and implementation of AstraZeneca’s Intensified Fed Batch platform process. Manos earned his B.S. in Chemical Engineering and M.S. in Biotechnology from the University of Maryland, Baltimore County (UMBC). Prior to joining AstraZeneca, he contributed to the Vaccine Production Program at the Vaccine Research Center, NIAID, NIH, working in the Cell Culture Development group. His expertise and innovative contributions continue to advance drug substance manufacturing processes.

Agenda Sessions

  • Panel Discussion - From Pilot to Platform: What it Really Takes to Scale Intensified and Continuous Bioprocesses

    11:30am
  • Developing robust intensification strategies for next-generation biologics drug substance manufacturing

    9:30am